Invention Grant
![Substituted 2,3-dihydroimidazo[1,2-C]quinazoline salts](/docs/US/2017-05-02/US09636344B2/abs.jpg.600x600.jpg)
- Patent Title: Substituted 2,3-dihydroimidazo[1,2-C]quinazoline salts
-
Application No.: US14990350Application Date: 2016-01-07
-
Publication No.: US09636344B2Publication Date: 2017-05-02
- Inventor: Jan-Georg Peters , Hans-Christian Militzer , Hartwig Müller
- Applicant: Bayer Intellectual Property GmbH
- Applicant Address: DE Monheim
- Assignee: Bayer Intellectual Property GmbH
- Current Assignee: Bayer Intellectual Property GmbH
- Current Assignee Address: DE Monheim
- Agency: Morrison and Foerster LLP
- Priority: EP11161111 20110405
- Main IPC: A61K31/5377
- IPC: A61K31/5377 ; C07D487/04 ; A61K45/06
![Substituted 2,3-dihydroimidazo[1,2-C]quinazoline salts](/abs-image/US/2017/05/02/US09636344B2/abs.jpg.150x150.jpg)
Abstract:
The present invention relates to 2-amino-N-[7-methoxy-8-(3-morpholin-4-ylpropoxy)-2,3-dihydroimidazo-[1,2-c]quinazolin-5-yl]pyrimidine-5-carboxamide dihydrochloride salt of formula (II): or a tautomer, solvate or hydrate thereof; and to its use for the treatment of non-Hodgkin's lymphoma.
Public/Granted literature
- US20160193219A1 SUBSTITUTED 2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLINE SALTS Public/Granted day:2016-07-07
Information query
IPC分类:
